SERD

What SERD Means in Everyday Medical Language

A selective estrogen receptor degrader, or SERD, is a type of drug used in hormone therapy for breast cancer. These drugs work by attaching to estrogen receptors found on some breast cancer cells and causing those receptors to break down. Estrogen receptors are proteins that allow cancer cells to respond to the hormone estrogen, which can encourage their growth. By breaking down these receptors, SERDs help block estrogen’s ability to stimulate cancer cells.

Why SERDs Matter in Cancer Care

Many breast cancers are estrogen receptor-positive, meaning they grow in response to estrogen. Hormone therapies that block estrogen or its effects can help control these cancers. However, sometimes cancer cells become resistant to common hormone treatments like selective estrogen receptor modulators (SERMs) or aromatase inhibitors. SERDs offer a different approach by not only blocking estrogen but also causing the estrogen receptors themselves to be destroyed. This can be especially helpful when other hormone therapies stop working.

What Patients Might See or Hear About SERDs

If your doctor mentions a SERD, it may be as part of a treatment plan for breast cancer that is estrogen receptor-positive and HER2-negative. Common SERDs include fulvestrant (brand name Faslodex) and elacestrant (brand name Orserdu). You might see these names in your medical records, treatment discussions, or medication lists. It’s important to ask your care team how these drugs fit your specific cancer type and treatment history.

Where the Term SERD Might Appear

The term SERD can appear in various places such as pathology reports describing hormone receptor status, treatment plans, drug information sheets, or clinical trial descriptions. Because SERDs have both generic and brand names, comparing these can help avoid confusion. For example, fulvestrant is also called Faslodex, and elacestrant is known as Orserdu.

What SERD Does Not Automatically Mean

Seeing the term SERD or the name of a SERD drug does not mean a diagnosis or treatment decision is finalized. It is a category of drugs used for specific types of breast cancer. Not all breast cancers respond to SERDs, and their use depends on factors like hormone receptor status, gene mutations, and previous treatments. Always discuss with your healthcare team what the term means for your individual care.

Common Questions to Ask Your Care Team

You might want to ask why a SERD is recommended for you, how it works differently from other hormone therapies, what side effects to expect, and how your cancer’s specific features, such as ESR1 gene mutations, affect treatment choices. Also, ask how your response to treatment will be monitored and what other options exist if needed.

Understanding SERDs in Context

SERDs are one part of hormone therapy options for breast cancer. They are especially useful when cancer cells have become resistant to other hormone treatments. Knowing about SERDs can help you understand your treatment plan better, but it’s important to see the term as part of a larger picture that includes your cancer type, test results, and overall health.

Safety and Next Steps

This information is educational and does not replace medical advice. If you see the term SERD or a related drug name in your records or discussions, the best next step is to ask your care team what it means for your specific situation. They can explain how this treatment fits your cancer care and what to expect moving forward.